ADDF – Harrington Scholar Award – LOI
Well-being, Health and Biomedical Discovery
Deadlines
Academic Unit: Inquire within unit
Memorial Deadline: RIS review not required for LOI
External Deadline: Monday 29th, May 2023
Description
Ph.D. or M.D. or equivalent required for eligibility. Open to researchers in the US, UK and Canada.
Letters of Intent (LOI) Due: May 29, 2023
Harrington Discovery Institute and the Alzheimer’s Drug Discovery Foundation (ADDF) invite you to submit a letter of intent (LOI) for the 2023 ADDF-Harrington Scholar Award. This grant is designed to accelerate the translation of academic discoveries into medicines for treating, preventing, or curing patients with Alzheimer’s disease and related dementias. Of particular interest are targets related to neurovascular health and glymphatic clearance. Researchers working on drug development programs that are relevant to, but not presently focused on, the Alzheimer’s field are strongly encouraged to apply. In addition to grant funding, Harrington Discovery Institute provides guidance and oversight in all aspects of drug development, while taking no rights to intellectual property, which is retained by you/your institution.
Pending how far an applicant makes it in the review process, we may be able to provide reviewers’ comments and feedback to help the applicant strengthen the proposal for future submission.
Visit our website to learn more about the ADDF-Harrington Scholar program.
To submit an LOI online, go to ADDF’s grant system and create an account.
Questions? Email grants@alzdiscovery.org or Questions@HarringtonDiscovery.org.
Scientific inquiries? Email Meriel Owen, PhD, ADDF at mowen@alzdiscovery.org.